Polycythemia means your blood has too many red blood cells. The answer to whether it runs in families depends entirely on which type you have. One form is caused by an acquired gene change that is not inherited. A separate group of rarer forms is genuinely inherited and can affect multiple family members. Some cases have no identified genetic cause at all.
Understanding which category you or a relative falls into matters. It changes how the condition is monitored, what treatments are considered, and whether other family members should be tested. This article breaks down the genetics honestly, including where the evidence is solid and where it is still limited.
What Are the Main Types of Polycythemia?
Doctors divide polycythemia into two broad categories: primary and secondary. The distinction is about where the problem starts.
In primary polycythemia, the bone marrow itself produces too many red blood cells. The most common form is polycythemia vera (PV), a type of myeloproliferative neoplasm. This means the bone marrow’s blood-forming stem cells behave abnormally. PV is not inherited in the usual sense, even though it involves a genetic mutation.
In secondary polycythemia, the bone marrow is responding normally to a signal from somewhere else. That signal is usually erythropoietin (EPO), a hormone that tells the marrow to make red blood cells. When tissues are chronically short on oxygen, the body makes more EPO. This can happen with chronic lung disease, sleep apnea, certain heart conditions, or living at high altitude. Smoking is a common contributor because carbon monoxide binds to hemoglobin and reduces oxygen delivery.
A third category is sometimes described: relative or apparent polycythemia. Here, red blood cell mass is normal, but plasma volume is low. The blood looks concentrated on a lab test, but the body is not actually overproducing red cells. Dehydration and diuretic use are common causes.
Is Polycythemia Vera Inherited?
No. Polycythemia vera is not passed from parent to child in the way a classic inherited disease is.
PV is driven by a somatic mutation — a gene change acquired during a person’s lifetime in a single blood-forming cell. The most common mutation is in the JAK2 gene, found in the vast majority of people with PV. Because this change happens in the bone marrow after birth, it is not present in sperm or eggs. That means it cannot be transmitted to children.
There is a real but small piece of nuance here. Having a first-degree relative with PV may slightly raise a person’s risk compared with the general population. Some research suggests a shared genetic susceptibility — common gene variants that make someone modestly more likely to develop the mutation — rather than direct inheritance of the disease. The absolute risk remains low. PV is uncommon overall, and the great majority of people who develop it have no family history.
This is an important distinction. A slight increase in susceptibility is not the same as an inherited disease. It does not mean children of someone with PV will develop it.
Which Forms of Polycythemia Are Actually Hereditary?
There is a group of genuinely inherited conditions called congenital polycythemias. These are rare. They are present from birth and result from gene changes carried in a family.
The best understood example involves changes in the gene for the erythropoietin receptor (EPOR). A specific type of EPOR mutation makes the receptor oversensitive to EPO. The bone marrow responds more strongly than it should, producing extra red blood cells. This form is inherited in an autosomal dominant pattern, meaning a single copy of the altered gene from one parent is enough to cause the condition.
Other inherited forms affect the oxygen-sensing pathway. The body regulates red blood cell production partly through a system that detects oxygen levels. Genes in this pathway include VHL, EGLN1 (also called PHD2), and EPAS1 (HIF-2 alpha). Changes in these genes can cause the body to behave as though oxygen is low even when it is not, driving red blood cell production upward.
These conditions can be passed down through families and may affect multiple relatives across generations. They are far less common than polycythemia vera.
How Do Doctors Tell the Difference?
Distinguishing inherited from acquired polycythemia requires testing, not guesswork. The pattern of lab results and the presence or absence of specific mutations guide the diagnosis.
| Feature | Polycythemia Vera | Congenital (Inherited) Polycythemia |
|---|---|---|
| Typical age at diagnosis | Often after age 50, but can occur earlier | Often detected in childhood or young adulthood |
| Family history | Usually none | Often present |
| JAK2 mutation | Present in most cases | Absent |
| EPO level | Usually low | Normal or elevated |
| Inheritance | Not inherited | Can be inherited |
Key tests include a complete blood count, an erythropoietin level, and JAK2 mutation testing. A low EPO level with a positive JAK2 mutation points strongly toward PV. A normal or high EPO level with no JAK2 mutation, especially with a family history, raises suspicion for an inherited form.
When an inherited cause is suspected, genetic testing may look at the EPOR gene, the oxygen-sensing pathway genes, or use a broader gene panel. Sometimes the specific gene is never identified, even when a hereditary pattern seems likely. This is an honest limitation of current testing.
When Should You Consider Genetic Testing or Family Screening?
Testing is not routine for everyone with a high red blood cell count. The decision depends on the clinical picture.
Genetic testing is most reasonable when:
- Polycythemia appears in a young person with no obvious secondary cause
- Multiple family members have elevated red blood cell counts
- JAK2 mutation testing is negative but the cause remains unclear
- Erythropoietin levels are normal or high rather than low
- There is an unusual pattern of symptoms or complications
For confirmed inherited forms, first-degree relatives may be offered testing. This is a decision to make with a doctor and, ideally, a genetic counselor. Not every inherited form causes problems, and some people who carry a mutation never develop significant symptoms. Screening decisions should weigh that reality.
No clinical guidelines currently recommend universal screening of relatives for all polycythemia types. This is an area where practice varies and depends on the specific condition involved.
What About Secondary Polycythemia and Genetics?
Most secondary polycythemia is not genetic at all. It reflects the body’s normal response to a real or perceived oxygen shortage.
Common non-genetic causes include chronic obstructive pulmonary disease, sleep apnea, certain congenital heart defects that allow blood to bypass the lungs, and long-term cigarette smoking. Living at high altitude is another well-established cause. In these situations, the bone marrow is doing exactly what it should — making more red blood cells because the body senses it needs them.
A small number of secondary polycythemia cases do have a genetic basis. The oxygen-sensing pathway mutations mentioned earlier can cause the body to overproduce EPO or to respond as if oxygen were low. These overlap with the inherited category and are sometimes grouped together under congenital polycythemia.
The practical point: if a doctor finds secondary polycythemia, the first step is usually to look for a treatable underlying cause like sleep apnea or smoking, not to order genetic tests.
What Are the Symptoms and Risks?
Many people with mild polycythemia have no symptoms at all. When symptoms occur, they relate to increased blood thickness and reduced blood flow.
Common symptoms can include headache, dizziness, blurred vision, fatigue, itching after a warm shower (more typical of PV), and a reddish or flushed face. Some people develop gout or an enlarged spleen.
The main concern with polycythemia is an increased risk of blood clots. Thicker blood flows less easily, and this raises the chance of clots in the veins and arteries. The degree of risk varies by type and by how high the red blood cell count climbs. It also depends on other risk factors like age and prior clot history.
This is why polycythemia is taken seriously even when symptoms are mild. Treatment aims to lower the red blood cell count and reduce clot risk. The specifics depend on the type and the individual.
Frequently Asked Questions
Can polycythemia vera be passed to my children?
No. Polycythemia vera is caused by a gene mutation acquired during life, not one inherited from a parent, so it is not passed to children. A small shared susceptibility may run in families, but the disease itself is not inherited.
Is a high red blood cell count always genetic?
No. Most high red blood cell counts are caused by factors like smoking, sleep apnea, chronic lung disease, or high altitude, not genetics. Only a small fraction of cases involve an inherited condition.
What gene causes inherited polycythemia?
Several genes can be involved, including EPOR and genes in the oxygen-sensing pathway such as VHL, EGLN1, and EPAS1. No single gene accounts for all inherited cases, and sometimes no specific gene is identified.
Should my family members be tested if I have inherited polycythemia?
Possibly. For confirmed inherited forms, testing first-degree relatives may be offered, but this decision should be made with a doctor or genetic counselor. No current guidelines recommend universal screening for all types.
Polycythemia is not one condition, and its genetics are not one answer. The common form, polycythemia vera, is driven by an acquired mutation that is not inherited. A rarer group of congenital forms is genuinely hereditary and can run in families. Most secondary polycythemia has nothing to do with genetics at all. Getting the right diagnosis is what makes the genetic question answerable — and that starts with proper testing, not assumptions.
